BLACU
Income statement / Annual
Last year (2024), Bellevue Life Sciences Acquisition Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Bellevue Life Sciences Acquisition Corp.'s net income was -$2.41 M.
See Bellevue Life Sciences Acquisition Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$3.52 M
|
$1.83 M
|
$35,388.00
|
$3,308.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$3.52 M
|
$1.83 M
|
$35,388.00
|
$3,308.00
|
$23,812.00
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$3.52 M
|
$1.83 M
|
$35,388.00
|
$3,308.00
|
$23,812.00
|
| Cost And Expenses |
$0.00
|
$1.83 M
|
$35,388.00
|
$3,308.00
|
$23,812.00
|
| Interest Income |
$2,181.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
-$43,011.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$2.78 M
|
$228,485.00
|
$236,558.00
|
$206,297.00
|
| EBITDA |
-$3.52 M |
$944,591.00 |
-$35,388.00 |
-$3,308.00 |
-$23,810.00 |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$1.41 M
|
$2.78 M
|
$0.00
|
$0.00
|
-$2.00
|
| Income Before Tax |
-$2.12 M
|
$944,591.00
|
-$35,388.00
|
-$3,308.00
|
-$23,812.00
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
-$295,728.00
|
$540,811.00
|
-$228,483.00
|
-$236,556.00
|
-$206,297.00
|
| Net Income |
-$2.41 M
|
$403,780.00
|
-$35,388.00
|
-$3,308.00
|
-$23,812.00
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.54 |
0.0718 |
-0.0039 |
-0.0004 |
-0.003 |
| EPS Diluted |
-0.54 |
0.0718 |
-0.0039 |
-0.0004 |
-0.003 |
| Weighted Average Shares Out |
$4.48 M
|
$5.62 M
|
$9.06 M
|
$7.93 M
|
$7.89 M
|
| Weighted Average Shares Out Diluted |
$4.48 M
|
$5.62 M
|
$9.06 M
|
$7.93 M
|
$7.89 M
|
| Link |
|
|
|
|
|
